BSE Live
Apr 13, 16:01Prev. Close
97.83
Open Price
97.83
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Pharmasia (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -2.33 | -0.76 | -1.84 | -2.27 | 0.46 | |
| Diluted EPS (Rs.) | -2.33 | -0.76 | -1.84 | -2.27 | 0.46 | |
| Cash EPS (Rs.) | -1.86 | -0.26 | -1.32 | -1.84 | 0.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 6.58 | 8.87 | 9.62 | 11.45 | 13.79 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 12.80 | 15.08 | 15.83 | 17.66 | 20.00 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 35.69 | 44.81 | 40.27 | 25.22 | 29.14 | |
| PBDIT/Share (Rs.) | -1.86 | -0.23 | -1.50 | -1.85 | 1.22 | |
| PBIT/Share (Rs.) | -2.32 | -0.74 | -2.03 | -2.28 | 0.72 | |
| PBT/Share (Rs.) | -2.35 | -0.80 | -2.10 | -2.29 | 0.70 | |
| Net Profit/Share (Rs.) | -2.33 | -0.76 | -1.84 | -2.27 | 0.46 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -5.19 | -0.51 | -3.73 | -7.35 | 4.18 | |
| PBIT Margin (%) | -6.51 | -1.64 | -5.04 | -9.04 | 2.46 | |
| PBT Margin (%) | -6.57 | -1.78 | -5.20 | -9.07 | 2.40 | |
| Net Profit Margin (%) | -6.52 | -1.69 | -4.58 | -8.98 | 1.56 | |
| Return on Networth / Equity (%) | -35.35 | -8.55 | -19.16 | -19.78 | 3.31 | |
| Return on Capital Employed (%) | -17.72 | -4.76 | -12.45 | -12.61 | 3.49 | |
| Return on Assets (%) | -7.37 | -1.64 | -4.43 | -7.29 | 1.42 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Asset Turnover Ratio (%) | 0.92 | 1.02 | 1.11 | 0.80 | 0.72 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.65 | 0.86 | 0.87 | 0.94 | 1.09 | |
| Quick Ratio (X) | 0.41 | 0.45 | 0.50 | 0.46 | 0.76 | |
| Inventory Turnover Ratio (X) | 4.22 | 3.23 | 4.55 | 4.17 | 2.86 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 19.65 | 19.23 | 15.29 | 20.94 | 16.63 | |
| EV/Net Operating Revenue (X) | 0.81 | 0.63 | 0.56 | 1.22 | 0.84 | |
| EV/EBITDA (X) | -15.51 | -121.65 | -14.88 | -16.55 | 20.00 | |
| MarketCap/Net Operating Revenue (X) | 0.82 | 0.65 | 0.58 | 1.23 | 0.85 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 4.45 | 3.28 | 2.43 | 2.70 | 1.80 | |
| Price/Net Operating Revenue | 0.82 | 0.65 | 0.58 | 1.23 | 0.85 | |
| Earnings Yield | -0.08 | -0.03 | -0.08 | -0.07 | 0.02 |
10.02.2026
Pharmasia Standalone December 2025 Net Sales at Rs 16.05 crore, up 239.94% Y-o-Y
24.11.2025
Pharmasia Standalone September 2025 Net Sales at Rs 16.55 crore, up 179.33% Y-o-Y
09.09.2025
Pharmasia Standalone June 2025 Net Sales at Rs 6.87 crore, down 17.1% Y-o-Y
10.06.2025
Pharmasia Standalone March 2025 Net Sales at Rs 5.43 crore, down 45.64% Y-o-Y
10.02.2026
Pharmasia Standalone December 2025 Net Sales at Rs 16.05 crore, up 239.94% Y-o-Y
24.11.2025
Pharmasia Standalone September 2025 Net Sales at Rs 16.55 crore, up 179.33% Y-o-Y
09.09.2025
Pharmasia Standalone June 2025 Net Sales at Rs 6.87 crore, down 17.1% Y-o-Y
10.06.2025
Pharmasia Standalone March 2025 Net Sales at Rs 5.43 crore, down 45.64% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth